Published in Infect Immun on April 01, 1980
Cytokine appearance and effects of anti-tumor necrosis factor alpha antibodies in a neonatal rat model of group B streptococcal infection. Infect Immun (1993) 1.56
Molecular species of R-protein antigens produced by clinical isolates of group B streptococci. J Clin Microbiol (1989) 1.54
Group B, type III streptococcal cell wall: composition and structural aspects revealed through endo-N-acetylmuramidase-catalyzed hydrolysis. Infect Immun (1982) 1.52
Synthesis and immunological properties of conjugates composed of group B streptococcus type III capsular polysaccharide covalently bound to tetanus toxoid. Infect Immun (1990) 1.43
Factors influencing release of type III antigens by group B streptococci. Infect Immun (1981) 1.41
Biosynthesis of cell wall peptidoglycan and polysaccharide antigens by protoplasts of type III group B Streptococcus. J Bacteriol (1983) 1.28
Correlation between the production of extracellular substances by type III group B streptococcal strains and virulence in a mouse model. Infect Immun (1981) 1.24
Adherence of group B streptococci to adult and neonatal epithelial cells mediated by lipoteichoic acid. Infect Immun (1987) 1.24
Type-specific capsular antigen is associated with virulence in late-onset group B Streptococcal type III disease. Infect Immun (1984) 1.20
Extracellular antigens of serotype III group B streptococci. Infect Immun (1980) 1.16
Induction of tumor necrosis factor alpha by the group- and type-specific polysaccharides from type III group B streptococci. Infect Immun (1994) 1.16
Immunochemical analysis and immunogenicity of the type II group B streptococcal capsular polysaccharide. J Clin Invest (1983) 1.15
Conservation of cell wall peptidoglycan by strains of Streptococcus mutans and Streptococcus sanguis. Infect Immun (1980) 1.12
Isolation and characterization of type III group B streptococcal mutants defective in biosynthesis of the type-specific antigen. Infect Immun (1983) 1.08
Decreased capacity for type-specific-antigen synthesis accounts for high prevalence of nontypeable strains of group B streptococci in Mexico. J Clin Microbiol (1997) 1.06
Sialylation of group B streptococcal capsular polysaccharide is mediated by cpsK and is required for optimal capsule polymerization and expression. J Bacteriol (2005) 1.06
Estimation of group B streptococcus type III polysaccharide-specific antibody concentrations in human sera is antigen dependent. Infect Immun (1998) 1.03
Soluble antigens from group B streptococci induce cytokine production in human blood cultures. Infect Immun (1997) 1.01
Immunospecificity and quantitation of an enzyme-linked immunosorbent assay for group B streptococcal antibody. J Clin Microbiol (1982) 0.98
Detection of group B streptococcal antigens in amniotic fluid of rhesus monkeys. J Clin Microbiol (1983) 0.97
Human monocyte receptors involved in tumor necrosis factor responses to group B streptococcal products. Infect Immun (2000) 0.91
Comparison of commercially available group B streptococcal latex agglutination assays. J Clin Microbiol (1991) 0.90
Monoclonal antibody to streptococcal group B carbohydrate: applications in latex agglutination and immunoprecipitin assays. J Clin Microbiol (1982) 0.90
Type-specific protection of neonatal rats from lethal group B streptococcal infection by immune sera obtained from human volunteers vaccinated with type III-specific polysaccharide. Infect Immun (1982) 0.89
Isolation, chemical composition, and molecular size of extracellular type II and type Ia polysaccharides of group B streptococci. Infect Immun (1983) 0.88
Quantitation of in vitro opsonic activity of human antibody induced by a vaccine consisting of the type III-specific polysaccharide of group B streptococcus. Infect Immun (1983) 0.85
FbsC, a novel fibrinogen-binding protein, promotes Streptococcus agalactiae-host cell interactions. J Biol Chem (2014) 0.84
Immunoglobulin G and M composition of naturally occurring antibody to type III group B streptococci. Infect Immun (1984) 0.83
The alpha-L-(1----2)-trirhamnopyranoside epitope on the group-specific polysaccharide of group B streptococci. Infect Immun (1991) 0.82
Role of Toll-like receptor 13 in innate immune recognition of group B streptococci. Infect Immun (2014) 0.82
Association of bacterial carbohydrate-specific cold agglutinin antibody production with immunization by group C, group B type III, and Streptococcus pneumoniae type XIV streptococcal vaccines. Infect Immun (1983) 0.78
Isotype antibody response in cows to Streptococcus agalactiae group B polysaccharide-ovalbumin conjugate. J Clin Microbiol (1992) 0.78
Bacterial glycobiology: rhamnose-containing cell wall polysaccharides in Gram-positive bacteria. FEMS Microbiol Rev (2016) 0.77
Rapid detection of group B streptococcal antigen in human amniotic fluid. J Clin Microbiol (1987) 0.75
Absence of significant cellulase activity in microbial flora of the female genital tract. Infect Immun (1987) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J (1956) 124.75
Detection of sugars on paper chromatograms. Nature (1950) 52.74
[A micro-method of immuno-electrophoresis]. Int Arch Allergy Appl Immunol (1955) 52.23
The thiobarbituric acid assay of sialic acids. J Biol Chem (1959) 43.78
Diffusion-in-gel methods for immunological analysis. Prog Allergy (1958) 27.50
The role of polyamines in the neutralization of bacteriophage deoxyribonucleic acid. J Biol Chem (1960) 21.21
Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids. Biochem J (1961) 17.21
Group B streptococcal neonatal and infant infections. J Pediatr (1973) 10.25
Growth of several cariogenic strains of oral streptococci in a chemically defined medium. Infect Immun (1975) 9.48
Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens. J Exp Med (1975) 7.02
Distribution by serological type of group B streptococci isolated from a variety of clinical material over a five-year period (with special reference to neonatal sepsis and meningitis). Infect Immun (1973) 7.01
Type-specific antigens of group B type Ic streptococci. Infect Immun (1971) 6.84
An immunological relationship between the group. A streptococcus and mammalian muscle. J Exp Med (1966) 4.89
Type-specific polysaccharide antigens of group B streptococci. J Hyg (Lond) (1966) 4.55
Group B streptococcal infections in infants. The importance of the various serotypes. JAMA (1974) 3.71
ANTIGENIC RELATIONSHIPS BETWEEN GROUPS B AND G STREPTOCOCCI. J Exp Med (1964) 3.70
The emergence of group B streptococci in infections of the newborn infant. Annu Rev Med (1977) 3.07
Type-specific polysaccharide antigens of group B streptococci. II. The chemical basis for serological specificity of the type II HCl antigen. J Exp Med (1967) 2.92
Immunochemistry of purified polysaccharide type antigens of group B streptococcal types Ia, Ib, and Ic. Infect Immun (1975) 2.83
The spectrum of group B streptococcal infections in infancy. Am J Dis Child (1974) 2.72
Immunochemical characterization of the "native" type III polysaccharide of group B Streptococcus. J Exp Med (1976) 2.55
Immunodeterminant specificity of human immunity to type III group B streptococcus. J Exp Med (1979) 2.06
The isolation and some physiochemical and biologic properties of the type 3 antigen of group B streptococci. J Immunol (1972) 2.04
Studies on the group F antigen of lactobacilli: antigenicity and serological specificity of teichoic acid preparations. J Gen Microbiol (1970) 1.84
Extracellular neuraminidase production by group B streptococci. Infect Immun (1977) 1.53
Multiple polysaccharide antigens of group B streptococcus, type Ia: emphasis on a sialic acid type-specific polysaccharide. J Immunol (1977) 1.45
Editorial: Group B streptococci: a serious threat to the neonate. JAMA (1974) 1.22
Immunochemical characterization of native polysaccharides from group B streptococcus: the relationship of the type III and group B determinants. J Immunol (1978) 1.18
Antigens of Streptococcus mutans: cellular localization of the serotype-specific polysaccharide of strain AHT and release during exponential growth. Infect Immun (1979) 1.06
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect (2011) 17.47
Growth of several cariogenic strains of oral streptococci in a chemically defined medium. Infect Immun (1975) 9.48
Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J Clin Microbiol (2007) 7.30
The autolytic enzyme system of Streptococcus faecalis. II. Partial characterization of the autolysin and its substrate. Biochemistry (1967) 5.83
Procaryotic cell division with respect to wall and membranes. CRC Crit Rev Microbiol (1971) 5.50
Symposium on the fine structure and replication of bacteria and their parts. IV. Unbalanced cell-wall synthesis: autolysis and cell-wall thickening. Bacteriol Rev (1965) 4.66
Model for cell wall growth of Streptococcus faecalis. J Bacteriol (1970) 3.99
Autolytic enzyme system of Streptococcus faecalis. 3. Localization of the autolysin at the sites of cell wall synthesis. J Bacteriol (1967) 3.50
Problems of cell wall and membrane growth, enlargement, and division. Ann N Y Acad Sci (1974) 3.45
Autolytic enzyme system of Streptococcus faecalis. V. Nature of the autolysin-cell wall complex and its relationship to properties of the autolytic enzyme of Streptococcus faecalis. J Bacteriol (1969) 3.25
Turnover of bacterial cell wall peptidoglycans. J Biol Chem (1973) 3.05
Synthesis and excretion of glycerol teichoic acid during growth of two streptococcal species. Infect Immun (1975) 3.03
Inhibition of bacterial wall lysins by lipoteichoic acids and related compounds. Biochem Biophys Res Commun (1975) 3.01
Balanced macromolecular biosynthesis in "protoplasts" of Streptococcus faecalis. J Bacteriol (1971) 2.77
Relationship between the latent form and the active form of the autolytic enzyme of Streptococcus faecalis. J Bacteriol (1969) 2.63
A modification of the Park and Johnson reducing sugar determination suitable for the assay of insoluble materials: its application to bacterial cell walls. Anal Biochem (1968) 2.53
Immunity to Salmonella typhimurium infection in C3H/HeJ and C3H/HeNCrlBR mice: studies with an aromatic-dependent live S. typhimurium strain as a vaccine. Infect Immun (1985) 2.40
Inhibition of wall autolysis in Streptococcus faecalis by lipoteichoic acid and lipids. J Bacteriol (1976) 2.39
Vitamin B6-dependent Streptococcus mitior (mitis) isolated from patients with systemic infections. J Infect Dis (1975) 2.37
Site of initiation of cellular autolysis in Streptococcus faecalis as seen by electron microscopy. J Bacteriol (1970) 2.37
Modular design of the Enterococcus hirae muramidase-2 and Streptococcus faecalis autolysin. FEMS Microbiol Lett (1992) 2.33
Early changes in the ultrastructure of Streptococcus faecalis after amino acid starvation. J Bacteriol (1970) 2.32
Amino acid requirements of Streptococcus mutans and other oral streptococci. Infect Immun (1975) 2.31
Relationship between the location of autolysin, cell wall synthesis, and the development of resistance to cellular autolysis in Streptococcus faecalis after inhibition of protein synthesis. J Bacteriol (1970) 2.26
Influence of macromolecular biosynthesis on cellular autolysis in Streptococcus faecalis. J Bacteriol (1972) 2.25
Study of cycle of cell wall assembly in Streptococcus faecalis by three-dimensional reconstructions of thin sections of cells. J Bacteriol (1976) 2.25
Clinical comparison of the Isolator 1.5 microbial tube and the BACTEC radiometric system for detection of bacteremia in children. J Clin Microbiol (1984) 2.24
Autolytic enzyme system of Streptococcus faecalis. IV. Electron microscopic observations of autolysin and lysozyme action. J Bacteriol (1968) 2.20
Evidence for O antigens as the antigenic determinants in "ribosomal" vaccines prepared from Salmonella. Infect Immun (1975) 2.16
A rapid, guantitative, and selective estimation of radioactively labeled peptidoglycan in gram-positive bacteria. Anal Biochem (1971) 2.16
Effect of inhibition of deoxyribonucleic acid and protein synthesis on the direction of cell wall growth in Streptococcus faecalis. J Bacteriol (1974) 2.15
Immunity to infection with Salmonella typhimurium: mouse-strain differences in vaccine- and serum-mediated protection. J Infect Dis (1984) 2.07
Effect of lipoteichoic acid and lipids on lysis of intact cells of Streptococcus faecalis. J Bacteriol (1976) 1.99
Autolytic defective mutant of Streptococcus faecalis. J Bacteriol (1978) 1.98
Precursor-product relationship of intracellular and extracellular lipoteichoic acids of Streptococcus faecium. J Bacteriol (1979) 1.97
Some properties of two autolytic-defective mutants of Streptococcus faecalis ATCC 9790. J Bacteriol (1972) 1.91
Dissociation of an autolytic enzyme-cell wall complex by treatment with unusually high concentrations of salt. Biochem Biophys Res Commun (1970) 1.90
Structure, function, and assembly of cell walls of gram-positive bacteria. Annu Rev Microbiol (1983) 1.80
Antimicrobial therapy of vitamin B6-dependent streptococcal endocarditis. Ann Intern Med (1977) 1.77
Intracellular pathogens: the role of antibody-mediated protection in Salmonella infection. Trends Microbiol (1998) 1.73
Opioids, opioid receptors, and the immune response. Drug Alcohol Depend (2001) 1.72
Morphological and physiological study of autolytic-defective Streptococcus faecium strains. J Bacteriol (1979) 1.72
Reinitiation of cell wall growth after threonine starvation of Streptococcus faecalis. J Bacteriol (1971) 1.71
The bacteriology of intra-abdominal infections. Surg Clin North Am (1975) 1.70
Purification and some properties of the endogenous, autolytic N-acetylmuramoylhydrolase of Streptococcus faecium, a bacterial glycoenzyme. J Biol Chem (1983) 1.69
Immunosuppression induced by nitric oxide and its inhibition by interleukin-4. Eur J Immunol (1992) 1.67
Biological properties of an immunogenic pneumococcal subcellular preparation. Infect Immun (1976) 1.67
Inhibition of peptidoglycan, ribonucleic acid, and protein synthesis in tolerant strains of Streptococcus mutans. Antimicrob Agents Chemother (1980) 1.65
Some properties of the autolytic N-acetylmuramidase of Lactobacillus acidophilus. J Bacteriol (1973) 1.57
Comparative efficacy and toxicity of a ribosomal vaccine, acetone-killed cells, lipopolysaccharide, and a live cell vaccine prepared from Salmonella typhhimurium. Infect Immun (1978) 1.56
Group B, type III streptococcal cell wall: composition and structural aspects revealed through endo-N-acetylmuramidase-catalyzed hydrolysis. Infect Immun (1982) 1.52
Cellular immunity induced by avirulent Salmonella in LPS-defective C3H/HeJ mice. J Immunol (1984) 1.48
Identification of Streptococcus pneumoniae with a DNA probe. J Clin Microbiol (1992) 1.48
The synthesis and secretion of gamma-globulin by lymph node cells. 3. The slow acquisition of the carbohydrate moiety of gamma-globulin and its relationship to secretion. Proc Natl Acad Sci U S A (1968) 1.48
Membrane-bound DD-carboxypeptidase and LD-transpeptidase of Streptococcus faecalis ATCC 9790. Eur J Biochem (1974) 1.45
Development of vancomycin and lysostaphin resistance in a methicillin-resistant Staphylococcus aureus isolate. J Antimicrob Chemother (2001) 1.45
Nature of the cross-protective antigen in subcellular vaccines of Streptococcus pneumoniae. Infect Immun (1981) 1.43
Cellular autolytic activity in synchronized populations of Streptococcus faecium. J Bacteriol (1978) 1.43
Evidence for the synthesis of soluble peptidoglycan fragments by protoplasts of Streptococcus faecalis. J Bacteriol (1975) 1.39
Studies of the formation of peptide cross-links in the cell wall peptidoglycan of Streptococcus faecalis. J Biol Chem (1975) 1.39
Cloning and sequence analysis of the muramidase-2 gene from Enterococcus hirae. J Bacteriol (1992) 1.38
Development of anaerobic fecal flora in healthy newborn infants. J Pediatr (1977) 1.38
Immunity to Salmonella infection. Adv Exp Med Biol (1983) 1.35
Autolytic formation of protoplasts (autoplasts) of Streptococcus faecalis 9790: release of cell wall, autolysin, and formation of stable autoplasts. J Bacteriol (1974) 1.35
Does penicillin kill bacteria?. Rev Infect Dis (1980) 1.35
Human infection with Brucella canis. Ann Intern Med (1972) 1.32
Measurement of intracellular iodophilic polysaccharide in two cariogenic strains of Streptococcus mutans by cytochemical and chemical methods. Infect Immun (1974) 1.32
Cellular lysis of Streptococcus faecalis induced with triton X-100. J Bacteriol (1978) 1.32
Structural arrangement of polymers within the wall of Streptococcus faecalis. J Bacteriol (1978) 1.31
Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigen. Am J Obstet Gynecol (1984) 1.30
Dissociation of innate susceptibility to Salmonella infection and endotoxin responsiveness in C3HeB/FeJ mice and other strains in the C3H lineage. Infect Immun (1982) 1.28
Autolytic enzyme of Streptococcus faecalis: release of soluble enzyme from cell walls. Biochem Biophys Res Commun (1966) 1.26
Factors regulating cell wall thickening and intracellular iodophilic polysaccharide storage in Streptococcus mutans. Infect Immun (1977) 1.26
Relationship between cellular autolytic activity, peptidoglycan synthesis, septation, and the cell cycle in synchronized populations of Streptococcus faecium. J Bacteriol (1978) 1.25
Macrophage-mediated mitogenic suppression induced in mice of the C3H lineage by a vaccine strain of Salmonella typhimurium. Cell Immunol (1985) 1.25
The second peptidoglycan hydrolase of Streptococcus faecium ATCC 9790 covalently binds penicillin. J Bacteriol (1989) 1.25
Quantitative determination in human sera of vaccine-induced antibody to type-specific polysaccharides of group B streptococci using an enzyme-linked immunosorbent assay. J Infect Dis (1983) 1.23
Immunosuppression induced by attenuated Salmonella. Evidence for mediation by macrophage precursors. J Immunol (1991) 1.23
Correlation of the duration and magnitude of protection against Salmonella infection afforded by various vaccines with antibody titers. Infect Immun (1980) 1.21
Covalent modification of the beta-1,4-N-acetylmuramoylhydrolase of Streptococcus faecium with 5-mercaptouridine monophosphate. Proc Natl Acad Sci U S A (1988) 1.20
Morphine induces sepsis in mice. J Infect Dis (1997) 1.19
Differences in delayed-type hypersensitivity responses in various mouse strains in the C3H lineage infected with Salmonella typhimurium, strain SL3235. J Immunol (1984) 1.16
Evidence that the PBP 5 synthesis repressor (psr) of Enterococcus hirae is also involved in the regulation of cell wall composition and other cell wall-related properties. J Bacteriol (1996) 1.15
Synthesis and secretion of gamma-globulin by lymph node cells. II. The intracellular segregation of amino acid-labeled and carbohydrate-labeled gamma-globulin. J Biol Chem (1967) 1.15
Natural killer cells mediate protection induced by a Salmonella aroA mutant. Infect Immun (1992) 1.15
Peptidoglycan loss during hen egg white lysozyme-inorganic salt lysis of Streptococcus mutans. J Bacteriol (1981) 1.12
Conservation of cell wall peptidoglycan by strains of Streptococcus mutans and Streptococcus sanguis. Infect Immun (1980) 1.12
Anaerobic bacterial infections of the female genital tract. Obstet Gynecol (1973) 1.12
Division blocks in temperature-sensitive mutants of Streptococcus faecium (S. faecalis ATCC 9790). J Bacteriol (1983) 1.10
Sites of cellular autolysis in Lactobacillus acidophilus. J Bacteriol (1973) 1.09
Salmonella typhimurium infection in mice induces nitric oxide-mediated immunosuppression through a natural killer cell-dependent pathway. Infect Immun (1998) 1.08
The bacteriology of intra-abdominal infections. Arch Surg (1974) 1.07
Analysis of growth rate in sucrose-supplemented cultures of Streptococcus mutans. Infect Immun (1975) 1.07